Corcept Therapeutics Inc (CORT)
24.44
+0.47
(+1.96%)
USD |
NASDAQ |
May 07, 11:01
Corcept Therapeutics Market Cap: 2.544B for May 7, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 06, 2024 | 2.496B |
| May 03, 2024 | 2.553B |
| May 02, 2024 | 2.609B |
| May 01, 2024 | 2.486B |
| April 30, 2024 | 2.428B |
| April 29, 2024 | 2.433B |
| April 26, 2024 | 2.374B |
| April 25, 2024 | 2.312B |
| April 24, 2024 | 2.340B |
| April 23, 2024 | 2.388B |
| April 22, 2024 | 2.316B |
| April 19, 2024 | 2.383B |
| April 18, 2024 | 2.353B |
| April 17, 2024 | 2.388B |
| April 16, 2024 | 2.429B |
| April 15, 2024 | 2.404B |
| April 12, 2024 | 2.441B |
| April 11, 2024 | 2.473B |
| April 10, 2024 | 2.471B |
| April 09, 2024 | 2.644B |
| April 08, 2024 | 2.516B |
| April 05, 2024 | 2.617B |
| April 04, 2024 | 2.606B |
| April 03, 2024 | 2.668B |
| April 02, 2024 | 2.638B |
| Date | Value |
|---|---|
| April 01, 2024 | 2.678B |
| March 28, 2024 | 2.608B |
| March 27, 2024 | 2.621B |
| March 26, 2024 | 2.562B |
| March 25, 2024 | 2.553B |
| March 22, 2024 | 2.536B |
| March 21, 2024 | 2.562B |
| March 20, 2024 | 2.527B |
| March 19, 2024 | 2.510B |
| March 18, 2024 | 2.517B |
| March 15, 2024 | 2.405B |
| March 14, 2024 | 2.450B |
| March 13, 2024 | 2.505B |
| March 12, 2024 | 2.532B |
| March 11, 2024 | 2.459B |
| March 08, 2024 | 2.447B |
| March 07, 2024 | 2.420B |
| March 06, 2024 | 2.384B |
| March 05, 2024 | 2.400B |
| March 04, 2024 | 2.500B |
| March 01, 2024 | 2.491B |
| February 29, 2024 | 2.433B |
| February 28, 2024 | 2.453B |
| February 27, 2024 | 2.500B |
| February 26, 2024 | 2.394B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.123B
Minimum
May 31 2019
3.567B
Maximum
Feb 08 2021
2.277B
Average
2.365B
Median
Market Cap Benchmarks
| Ultragenyx Pharmaceutical Inc | 3.556B |
| Alnylam Pharmaceuticals Inc | 19.33B |
| Catalyst Pharmaceuticals Inc | 1.755B |
| United Therapeutics Corp | 11.62B |
| XOMA Corp | 290.64M |
Market Cap Related Metrics
| PE Ratio | 23.06 |
| PS Ratio | 5.152 |
| PEG Ratio | 0.7877 |
| Price to Book Value | 4.644 |
| Price to Free Cash Flow | 21.60 |
| Price | 24.44 |
| Earnings Yield | 4.34% |
| PEGY Ratio | 0.7877 |
| Operating PE Ratio | 22.12 |
| Normalized PE Ratio | 23.06 |